Immediate Impact
69 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Dimple Pandya being referenced
Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab
2022
Pharmacodynamics (PD) and genomic profiling of pts treated with cabiralizumab (cabira) + nivolumab (NIVO) provide evidence of on-target tumor immune modulations and support future clinical applications.
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Dimple Pandya | 119 | 26 | 60 | 40 | 11 | 165 | |
| James Pratt | 134 | 14 | 51 | 14 | 13 | 213 | |
| Minori Koshiji Rosales | 133 | 36 | 73 | 29 | 11 | 155 | |
| Renduo Shang | 62 | 19 | 71 | 20 | 9 | 190 | |
| Kees Bisschop | 118 | 20 | 40 | 38 | 7 | 175 | |
| Mojca Unk | 132 | 65 | 114 | 15 | 14 | 187 | |
| Dayang Hui | 112 | 35 | 63 | 47 | 13 | 267 | |
| Niko Kemi | 130 | 28 | 113 | 48 | 14 | 284 | |
| Sofia Westbom-Fremer | 181 | 38 | 96 | 66 | 12 | 287 | |
| Bo Yan | 88 | 17 | 33 | 60 | 13 | 194 | |
| Godehard Lahmer | 113 | 42 | 59 | 100 | 14 | 240 |
All Works
Loading papers...